These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38165905)

  • 41. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ.
    Mark E; Goldsman D; Keskinocak P; Sokol J
    Transpl Infect Dis; 2019 Dec; 21(6):e13181. PubMed ID: 31541522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy.
    Vaziri A; Gimson A; Agarwal K; Aldersley M; Bathgate A; MacDonald D; McPherson S; Mutimer D; Gelson W
    J Viral Hepat; 2019 Feb; 26(2):231-235. PubMed ID: 30339294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
    Sundaram V; Kogachi S; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Levitsky J; Rahimi RS; Jalan R
    J Hepatol; 2020 Mar; 72(3):481-488. PubMed ID: 31669304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of simultaneous and sequential pediatric liver and kidney transplantation.
    Rogers J; Bueno J; Shapiro R; Scantlebury V; Mazariegos G; Fung J; Reyes J
    Transplantation; 2001 Nov; 72(10):1666-70. PubMed ID: 11726829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evolution of liver transplant waiting list in Hungary between 1995 and 2019].
    Görög D; Gerlei Z; Schuller J; Dezsőfi A; Hartmann E; Piros L; Sandil A; Szabó J; Fehérvári I; Fazakas J; Doros A; Kóbori L
    Orv Hetil; 2022 Feb; 163(8):301-311. PubMed ID: 35184050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of liver transplantation for polycystic liver disease: a single center experience.
    Chandok N; Uhanova J; Marotta P
    Ann Hepatol; 2010; 9(3):278-81. PubMed ID: 20720268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
    Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
    HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Right Extended Split Liver Transplantation Compared With Whole Liver Transplantation: Lessons Learned at a Single Center in Latin America-Results From a Match Case-Control Study.
    Gambaro SE; Romero P; Pedraza N; Moulin L; Yantorno S; Ramisch D; Rumbo C; Barros-Schelotto P; Descalzi V; Gondolesi GE
    Transplant Proc; 2017 Nov; 49(9):2122-2128. PubMed ID: 29149972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics.
    Chungfat N; Dixler I; Cohran V; Buchman A; Abecassis M; Fryer J
    J Am Coll Surg; 2007 Dec; 205(6):755-61. PubMed ID: 18035258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Impact of the New Kidney Allocation System on Prior Living Kidney Donors' Access to Deceased Donor Kidney Transplants: An Early Look.
    Wainright JL; Kucheryavaya AY; Klassen DK; Stewart DE
    Am J Transplant; 2017 Apr; 17(4):1103-1111. PubMed ID: 27805305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis.
    Husain SA; King KL; Adler JT; Mohan S; Perotte R
    Am J Kidney Dis; 2022 Mar; 79(3):354-361. PubMed ID: 34562524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list.
    Porrett PM; Baranov E; ter Horst M
    Transplantation; 2015 Jan; 99(1):158-63. PubMed ID: 25050469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.
    Fosby B; Melum E; Bjøro K; Bennet W; Rasmussen A; Andersen IM; Castedal M; Olausson M; Wibeck C; Gotlieb M; Gjertsen H; Toivonen L; Foss S; Makisalo H; Nordin A; Sanengen T; Bergquist A; Larsson ME; Soderdahl G; Nowak G; Boberg KM; Isoniemi H; Keiding S; Foss A; Line PD; Friman S; Schrumpf E; Ericzon BG; Höckerstedt K; Karlsen TH
    Scand J Gastroenterol; 2015 Jun; 50(6):797-808. PubMed ID: 25959101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver transplantation in polycystic liver disease: a relevant treatment modality for adults?
    Krohn PS; Hillingsø JG; Kirkegaard P
    Scand J Gastroenterol; 2008 Jan; 43(1):89-94. PubMed ID: 18938751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reframing the impact of combined heart-liver allocation on liver transplant wait-list candidates.
    Goldberg DS; Reese PP; Amaral S; Abt PL
    Liver Transpl; 2014 Nov; 20(11):1356-64. PubMed ID: 25044621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
    Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
    J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.